Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESOLVE-CKD: Low-dose Colchicine for Cardiovascular Calcification in CKD
NCT07654231Phase 2Not yet recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Oct 2026
- Primary completion
- May 2029
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in Coronary artery calcification (CAC), sponsored by UT Southwestern Medical Center. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
colchicine
03
Conditions
Coronary artery calcification (CAC)
Beyond the preview
Go deeper on NCT07654231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07654231.